A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm
NCT00235963
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Subarachnoid Hemorrhage
Delayed Vasospasm
Interventions
DRUG:
Simvastatin
Sponsor
Brigham and Women's Hospital